Evidence map›Paper›PMID 32062624›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.

Kei Tachibana, Keita Matsuura, Akihiro Shindo, Hirofumi Matsuyama, Yuichiro Ii, Akira Taniguchi, Hidekazu Tomimoto

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kei TachibanaDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Keita MatsuuraDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Akihiro ShindoDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Hirofumi MatsuyamaDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Yuichiro IiDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Akira TaniguchiDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Hidekazu TomimotoDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Mie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective When patients take neuroleptics, the distinction between Parkinson's disease (PD) and drug-induced parkinsonism (DIP) based solely on clinical features can become difficult. At present,

Indexed as

AgedAged, 80 and overAntipsychotic AgentsDiagnosis, DifferentialFemaleFunctional NeuroimagingHumansMaleMiddle AgedParkinson DiseaseParkinson Disease, SecondaryParkinsonian DisordersSymptom AssessmentAntipsychotic Agentsasymmetricautonomic dysfunctiondopamine transporter single-photon emission computed tomographydrug induced parkinsonismParkinson diseasetremor

Identifiers

PMID32062624
PMCPMC7056363
OpenAlexW3005993629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.